AMRX
Price
$7.26
Change
-$0.16 (-2.16%)
Updated
May 21, 04:59 PM (EDT)
Capitalization
1.87B
78 days until earnings call
PAHC
Price
$23.24
Change
-$0.85 (-3.53%)
Updated
May 21, 04:59 PM (EDT)
Capitalization
523.71M
98 days until earnings call
Interact to see
Advertisement

AMRX vs PAHC

Header iconAMRX vs PAHC Comparison
Open Charts AMRX vs PAHCBanner chart's image
Amneal Pharmaceuticals
Price$7.26
Change-$0.16 (-2.16%)
Volume$31.63K
Capitalization1.87B
Phibro Animal Health
Price$23.24
Change-$0.85 (-3.53%)
Volume$2.03K
Capitalization523.71M
AMRX vs PAHC Comparison Chart
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. PAHC commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Hold and PAHC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (AMRX: $7.42 vs. PAHC: $24.09)
Brand notoriety: AMRX and PAHC are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 75% vs. PAHC: 163%
Market capitalization -- AMRX: $1.87B vs. PAHC: $523.71M
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. PAHC’s [@Pharmaceuticals: Other] market capitalization is $523.71M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.7B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whilePAHC’s FA Score has 1 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • PAHC’s FA Score: 1 green, 4 red.
According to our system of comparison, PAHC is a better buy in the long-term than AMRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 5 TA indicator(s) are bullish while PAHC’s TA Score has 6 bullish TA indicator(s).

  • AMRX’s TA Score: 5 bullish, 4 bearish.
  • PAHC’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, both AMRX and PAHC are a good buy in the short-term.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а -1.07% price change this week, while PAHC (@Pharmaceuticals: Other) price change was -2.07% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.86%. For the same industry, the average monthly price growth was +12.05%, and the average quarterly price growth was +27.92%.

Reported Earning Dates

AMRX is expected to report earnings on Aug 07, 2025.

PAHC is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.86% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRX($1.87B) has a higher market cap than PAHC($524M). AMRX has higher P/E ratio than PAHC: AMRX (90.00) vs PAHC (34.11). PAHC YTD gains are higher at: 11.269 vs. AMRX (-8.207). AMRX has higher annual earnings (EBITDA): 400M vs. PAHC (83.7M). PAHC (92.5M) and AMRX (91.5M) have equal amount of cash in the bank . PAHC has less debt than AMRX: PAHC (513M) vs AMRX (2.75B). AMRX has higher revenues than PAHC: AMRX (2.39B) vs PAHC (982M).
AMRXPAHCAMRX / PAHC
Capitalization1.87B524M357%
EBITDA400M83.7M478%
Gain YTD-8.20711.269-73%
P/E Ratio90.0034.11264%
Revenue2.39B982M244%
Total Cash91.5M92.5M99%
Total Debt2.75B513M536%
FUNDAMENTALS RATINGS
AMRX vs PAHC: Fundamental Ratings
AMRX
PAHC
OUTLOOK RATING
1..100
7224
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
23
Undervalued
PROFIT vs RISK RATING
1..100
5277
SMR RATING
1..100
9661
PRICE GROWTH RATING
1..100
5740
P/E GROWTH RATING
1..100
2492
SEASONALITY SCORE
1..100
1650

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PAHC's Valuation (23) in the Pharmaceuticals Major industry is significantly better than the same rating for AMRX (92). This means that PAHC’s stock grew significantly faster than AMRX’s over the last 12 months.

AMRX's Profit vs Risk Rating (52) in the Pharmaceuticals Major industry is in the same range as PAHC (77). This means that AMRX’s stock grew similarly to PAHC’s over the last 12 months.

PAHC's SMR Rating (61) in the Pharmaceuticals Major industry is somewhat better than the same rating for AMRX (96). This means that PAHC’s stock grew somewhat faster than AMRX’s over the last 12 months.

PAHC's Price Growth Rating (40) in the Pharmaceuticals Major industry is in the same range as AMRX (57). This means that PAHC’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's P/E Growth Rating (24) in the Pharmaceuticals Major industry is significantly better than the same rating for PAHC (92). This means that AMRX’s stock grew significantly faster than PAHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXPAHC
RSI
ODDS (%)
Bullish Trend 7 days ago
89%
Bearish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
62%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 3 days ago
69%
Declines
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 21 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FLUAX27.35N/A
N/A
Fidelity Advisor Stk Selec Lg Cp Val A
MENYX9.13N/A
N/A
Madison Covered Call & Equity Income Y
NPNAX46.72N/A
N/A
Neuberger Berman Large Cap Value A
CBBZX6.53N/A
N/A
AB Relative Value Z
CTIGX14.52-0.39
-2.62%
Calamos Timpani SMID Growth I

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with PAHC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
-2.02%
PAHC - AMRX
44%
Loosely correlated
-3.49%
HROW - AMRX
41%
Loosely correlated
-4.77%
VTRS - AMRX
38%
Loosely correlated
-4.50%
TEVA - AMRX
38%
Loosely correlated
-1.37%
ZTS - AMRX
37%
Loosely correlated
-1.35%
More

PAHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, PAHC has been loosely correlated with PBH. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if PAHC jumps, then PBH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAHC
1D Price
Change %
PAHC100%
-3.49%
PBH - PAHC
48%
Loosely correlated
-3.59%
AMRX - PAHC
43%
Loosely correlated
-2.02%
ZTS - PAHC
39%
Loosely correlated
-1.35%
VTRS - PAHC
33%
Loosely correlated
-4.50%
ALKS - PAHC
32%
Poorly correlated
-3.60%
More